X4 Pharmaceuticals, Taiba to Distribute Xolremdi in Select Middle East Countries

MT NewswiresFeb 19 10:53 ET

Express News | X4 Pharmaceuticals and Taiba Rare Announce Exclusive Agreement for the Distribution and Commercialization of Xolremdi® (Mavorixafor) in Whim Syndrome in Select Middle East Countries

ReutersFeb 19 07:35 ET

Insider Purchase: Chief Commercial Officer of $XFOR Buys 13,404 Shares

Quiver QuantitativeFeb 14 16:18 ET

X4 Pharmaceuticals Analyst Ratings

BenzingaFeb 7 07:37 ET · Ratings

Piper Sandler Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsFeb 7 07:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), X4 Pharmaceuticals (XFOR) and IQVIA Holdings (IQV)

TipRanksFeb 7 06:50 ET · Ratings